Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 60-65

  Michelet, Christian ^a,b   Avril, Jean Loup ^a   Arvieux, Cedric ^a   Jacquelinet, Christian ^a   Vu, Nicolas ^a   Cartier, Francois ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLINAFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; DRUG ANTAGONISM; DRUG PENETRATION; HELA CELL; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; MACROPHAGE ACTIVATION; MINIMUM INHIBITORY CONCENTRATION; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0031018693     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.60     Document Type: Article

References (20)

1. Anderson, R., and G. K. Joone. 1993. In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628. Chemotherapy 39:424-431.
2. Blanot, S., and P. Berche. 1995. In vivo activity of antibiotics against Listeria monocytogenes during experimental rhombencephalitis in gerbils, abstr. K212. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Calif. American Society for Microbiology, Washington, D.C.
3. Carlier, M. B., B. Scorneaux, A. Zenebergh, J. F. Desnottes, and P. M. Tulkens. 1990. Cellular uptake, localization, and activity of fluoroquinolones in uninfected and infected macrophages. J. Antimicrob. Chemother. 26(Suppl.):27-39.
4. Charpentier, E., G. Gerbaud, C. Jacquet, J. Recourt, and P. Courvalin. 1993. Incidence of antibiotic resistance in Listeria species. J. Infect. Dis. 172:277-281.
5. Cossart, P., and J. Mengaud. 1989. Listeria monocytogenes. A model system for the molecular study of intracellular parasitism. Mol. Biol. Med. 6:463-473.
6. Dorr, M. B., C. L. Webb, N. Bron, and A. B. Vassos. 1991. Single dose tolerance and pharmacokinetics of CI-960 (PD 127391) in healthy volunteers, abstr. 1154. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Ill. American Society for Microbiology, Washington, D.C.
7. Drugeon, H. B., and A. L. Courtieu. 1979. Comparaison des pouvoirs bactéricides de 4 aminosides: amikacine, gentamicine, kanamycine, et tobramycine. Ann. Microbiol. (Paris) 130:331-343.
8. Friedland, I. R., M. Paris, S. Ehrett, S. Hickey, K. Olsen, and G. H. McCracken. 1993. Evaluation of antimicrobial regimen for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 37:1630-1636.
9. Friedrich, L. V. R. L. White, and A. C. Reboli. 1990. Pharmacodynamics of trimethoprim-sulfamethoxazole in Listeria meningitis: a case report. Pharmacotherapy 10:301-304.
10. Gaillard, J. L., P. Berche, J. Mounier, S. Richard, and P. Sansonetti. 1987. In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect. Immun. 55:2922-2829.
11. Marchetti, P., A. Lepoutre, A. F. Miegeville, J. Rocourt, and V. Goulet. 1995. Listeriosis in non-pregnant adults in 1992 in France: clinical presentation of 225 cases, abstr. K212. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Calif. American Society for Microbiology, Washington, D.C.
12. Michelet, C., J. L. Avril, F. Cartier, and P. Berche. 1994, Inhibition of intracellular growth of Listeria monocytogenes by antibiotics. Antimicrob. Agents Chemother. 38:438-446.
13. Nakashima, M., T. Uematsu, M. Kanamaru, O. Okazaki, and H. Hakusui. 1992. Phase I study of levofloxacin, (s)-(-) ofloxacin. Jpn. J. Clin. Pharmacol.
14. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests. Approval standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Pinede, L., G. Manquat, D. Barnoud, M. Guignier, J. P. Stahl, and M. Micoud. 1993. Listeriose neuroméningée de l'adulte. Aspects cliniques et apport du cotrimoxazole en monothérapie. Presse Med. 22:1385-1390.
16. Preston, S. L., G. L. Drusano, A. L. Berman, C. L. Fowler, A. T. Chow, B. E. Dornseif, V. Reichl, J. Natarajan, and M. L. Corrado. 1996. Levofloxacin population pharmacokinetics and creation of a demographics model for prediction of individual drug clearance in patients with serious community-acquired infection, abstr. A12. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, La. American Society for Microbiology, Washington, D.C.
17. Richard, P., and L. Gutmann. 1992. Sparfloxacin and new fluoroquinolones. J. Antimicrob. Chemother. 30:739-744.
18. Spitzer, P. G., S. M. Hammer, and A. W. Karchmer. 1986. Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev. Infect. Dis. 8:427-430.
19. Tulkens, P. M. 1991. Intracellular distribution and activity of antibiotic. Eur. J. Clin. Microbiol. Infect. Dis. 10:100-106.
20. Van Ogtrop, M. L., H. Mattie, E. Van Strijen, and R. Van Furth. 1992. Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infection with Listeria monocytogenes in hydrocortisone pretreated mice. Antimicrob. Agents Chemother. 36:2375-2380.